Skip to main content

Table 3 Sensitivity analyses

From: The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis

Dataset

Posterior mean rate per 1000

95 % credible interval

All studies

0.51

0.16, 0.98

All studies; add 1 LMS case to largest study

0.59

0.21, 1.08

All studies; add 1 LMS case to smallest study

0.53

0.16, 1.02

All studies; reclassification based on histopathology

0.53

0.16, 0.99

Prospective studies

0.12

0, 0.75

Prospective studies; add 1 LMS case to largest study

0.36

0, 1.27

Prospective studies; add 1 LMS case to smallest study

0.13

0, 0.89

All studies; crude test rate

1.03

0.69, 1.43

All studies; actual crude rate

1.06

0.75, 1.50

  1. LMS leiomyosarcoma
  2. See text for explanation of adding LMS cases and reclassification.
  3. Crude test rate involved adding 32 LMS to 31 largest studies
  4. Actual crude rate is (number of LMS/number of total surgeries) for all studies
Back to article page